NHMAF(NHMAF)
NHMAF
No analyst ratings available
No analyst price targets available for NHMAF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $53.80B | $58.41B | $63.37B | $58.08B | $60.28B |
| Low | $51.27B | $53.67B | $59.26B | $54.32B | $56.37B |
| High | $55.06B | $60.58B | $65.31B | $59.86B | $62.12B |
| EBITDA Avg | $20.88B | $22.67B | $24.59B | $22.54B | $23.39B |
| Low | $19.90B | $20.83B | $23.00B | $21.08B | $21.88B |
| High | $21.37B | $23.51B | $25.34B | $23.23B | $24.11B |
| EBIT Avg | $20.65B | $22.42B | $24.33B | $22.30B | $23.14B |
| Low | $19.68B | $20.60B | $22.75B | $20.85B | $21.64B |
| High | $21.14B | $23.26B | $25.07B | $22.98B | $23.85B |
| Net Income Avg | $13.58B | $14.60B | $16.07B | $14.30B | $14.73B |
| Low | $12.43B | $13.37B | $14.71B | $13.09B | $13.49B |
| High | $14.12B | $15.18B | $16.71B | $14.86B | $15.32B |
| EPS Avg | $42.79 | $46.01 | $50.64 | $45.06 | $46.43 |
| Low | $39.19 | $42.13 | $46.38 | $41.26 | $42.52 |
| High | $44.49 | $47.84 | $52.66 | $46.85 | $48.28 |
| Analysts (Rev / EPS) | 6 / 1 | 6 / 1 | 5 / 1 | 3 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $14.16B | $16.36B | $12.23B |
| Low | $13.90B | $16.06B | $12.01B |
| High | $14.42B | $16.66B | $12.45B |
| EBITDA Avg | $5.50B | $6.35B | $4.75B |
| Low | $5.40B | $6.23B | $4.66B |
| High | $5.60B | $6.47B | $4.83B |
| EBIT Avg | $5.44B | $6.28B | $4.69B |
| Low | $5.34B | $6.17B | $4.61B |
| High | $5.54B | $6.40B | $4.78B |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 3 / — | 2 / — | 1 / — |